Avi Oler | VP, Corporate Development, General Counsel |
Steve Fruchtman | President and CEO |
Mark Guerin | CFO |
Ric Woodman | Chief Medical Officer |
Joe Pantginis | HC Wainwright |
Naureen Quibria | Maxim Group |
Ahu Demir | Noble Capital Markets |
Yale Jen | Laidlaw & Company |
Good morning and welcome to Onconova Therapeutics' Corporate Update and Second Quarter 2019 Financial Results Conference Call.
At this time, I would like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel.
Thank you, Operator. Good morning everybody, and welcome to Onconova's second quarter 2019 corporate update and financial results conference call. Earlier this morning, we issued a press release with second quarter 2019 financial results and business updates.